Cargando…
Efficacy of PARP inhibition in Pde6a mutant mouse models for retinitis pigmentosa depends on the quality and composition of individual human mutations
Retinitis pigmentosa (RP), an inherited blinding disease, is caused by a variety of different mutations that affect retinal photoreceptor function and survival. So far there is neither effective treatment nor cure. We have previously shown that poly(ADP-ribose)polymerase (PARP) acts as a common and...
Autores principales: | Jiao, K, Sahaboglu, A, Zrenner, E, Ueffing, M, Ekström, P A R, Paquet-Durand, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979439/ https://www.ncbi.nlm.nih.gov/pubmed/27551530 http://dx.doi.org/10.1038/cddiscovery.2016.40 |
Ejemplares similares
-
Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms
por: Sahaboglu, A, et al.
Publicado: (2013) -
Temporal progression of PARP activity in the Prph2 mutant rd2 mouse: Neuroprotective effects of the PARP inhibitor PJ34
por: Sahaboglu, Ayse, et al.
Publicado: (2017) -
Calpain and PARP Activation during Photoreceptor Cell Death in P23H and S334ter Rhodopsin Mutant Rats
por: Kaur, Jasvir, et al.
Publicado: (2011) -
PARP1 Gene Knock-Out Increases Resistance to Retinal Degeneration without Affecting Retinal Function
por: Sahaboglu, Ayse, et al.
Publicado: (2010) -
HDAC inhibition delays photoreceptor loss in Pde6b mutant mice of retinitis pigmentosa: insights from scRNA-seq and CUT&Tag
por: Dong, Yujie, et al.
Publicado: (2023)